Wafergen Bio-systems, Inc. Files SEC Form SC 13G, Statement of Acquisition of Beneficial Ownership By Individuals [Amend] (Jan. 12, 2015)

By a News Reporter-Staff News Editor at Economics Week -- According to news reporting originating from Washington, D.C., by VerticalNews journalists, a U.S. Securities and Exchange Commission (SEC) filing by Wafergen Bio-systems, Inc. (Form SC 13G) was posted on January 12, 2015.

The SIC code for this company is 3826, Laboratory Analytical Instruments.

There was one document filed with this form. The SEC file number is 0001535610-15-000030.

The contact information for this company is 7400 PASEO PADRE PARKWAY, FREMONT CA 94555, (510) 651-4450.

Our editors provided additional information about Form SC 13G: Schedule 13G is a much abbreviated version of Schedule 13D that is only available for use by a limited category of "persons" (such as banks, broker/dealers, and insurance companies) and even then only when the securities were acquired in the ordinary course of business and not with the purpose or effect of changing or influencing the control of the issuer.

A U.S. Securities and Exchange Commission filing is a formal document or financial statement submitted to the SEC by publicly-traded companies.

For additional information on this SEC filing see: http://www.sec.gov/Archives/edgar/data/1368993/0001535610-15-000030-index.html.

Keywords for this news article include: SEC Filing, Wafergen Bio-systems Inc, Laboratory Analytical Instruments.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2015, NewsRx LLC